347 related articles for article (PubMed ID: 22577110)
1. C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up.
Bo S; Gentile L; Castiglione A; Prandi V; Canil S; Ghigo E; Ciccone G
Eur J Endocrinol; 2012 Aug; 167(2):173-80. PubMed ID: 22577110
[TBL] [Abstract][Full Text] [Related]
2. C-peptide concentration, mortality and vascular complications in people with Type 2 diabetes. The Skaraborg Diabetes Register.
Pikkemaat M; Melander O; Mölstad S; Garberg G; Boström KB
Diabet Med; 2015 Jan; 32(1):85-9. PubMed ID: 25354243
[TBL] [Abstract][Full Text] [Related]
3. Relationship between C peptide and chronic complications in type-2 diabetes mellitus.
Sari R; Balci MK
J Natl Med Assoc; 2005 Aug; 97(8):1113-8. PubMed ID: 16173326
[TBL] [Abstract][Full Text] [Related]
4. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction.
Zoppini G; Targher G; Negri C; Stoico V; Gemma ML; Bonora E
Atherosclerosis; 2010 Sep; 212(1):287-91. PubMed ID: 20510417
[TBL] [Abstract][Full Text] [Related]
6. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
Grauslund J
Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
[TBL] [Abstract][Full Text] [Related]
7. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany.
Hoffmann F; Haastert B; Koch M; Giani G; Glaeske G; Icks A
Nephrol Dial Transplant; 2011 May; 26(5):1634-40. PubMed ID: 20959344
[TBL] [Abstract][Full Text] [Related]
8. HbA
Metcalf PA; Kyle C; Kenealy T; Jackson RT
J Diabetes Complications; 2017 May; 31(5):814-823. PubMed ID: 28319002
[TBL] [Abstract][Full Text] [Related]
9. Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: a population-based cohort study in Italy.
Cammarota S; Bruzzese D; Catapano AL; Citarella A; De Luca L; Manzoli L; Masulli M; Menditto E; Mezzetti A; Riegler S; Putignano D; Tragni E; Novellino E; Riccardi G
Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):10-7. PubMed ID: 23806740
[TBL] [Abstract][Full Text] [Related]
10. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
Theilade S; Hansen TW; Goetze JP; Rossing P
Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and incidence of chronic complications and mortality in a cohort of type 2 diabetic patients in Spain.
Mundet X; Pou A; Piquer N; Sanmartin MI; Tarruella M; Gimbert R; Farrus M
Prim Care Diabetes; 2008 Sep; 2(3):135-40. PubMed ID: 18779037
[TBL] [Abstract][Full Text] [Related]
13. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
Bo S; Castiglione A; Ghigo E; Gentile L; Durazzo M; Cavallo-Perin P; Ciccone G
Eur J Endocrinol; 2013 Jul; 169(1):117-26. PubMed ID: 23660643
[TBL] [Abstract][Full Text] [Related]
14. Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus.
Zoppini G; Negri C; Stoico V; Casati S; Pichiri I; Bonora E
Metabolism; 2012 Jan; 61(1):22-9. PubMed ID: 21676418
[TBL] [Abstract][Full Text] [Related]
15. Micro- and macrovascular outcomes in Type 2 diabetic patients treated with insulin glulisine or human regular insulin: a retrospective database analysis.
Kress S; Kostev K; Dippel FW; Giani G; Rathmann W
Int J Clin Pharmacol Ther; 2012 Nov; 50(11):821-9. PubMed ID: 22578200
[TBL] [Abstract][Full Text] [Related]
16. Association of Serum Markers of Oxidative Stress With Incident Major Cardiovascular Events, Cancer Incidence, and All-Cause Mortality in Type 2 Diabetes Patients: Pooled Results From Two Cohort Studies.
Xuan Y; Gào X; Anusruti A; Holleczek B; Jansen EHJM; Muhlack DC; Brenner H; Schöttker B
Diabetes Care; 2019 Aug; 42(8):1436-1445. PubMed ID: 31167893
[TBL] [Abstract][Full Text] [Related]
17. Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed diabetes.
Hsu CN; Chang CH; Lin YS; Lin JW; Caffrey JL
PLoS One; 2013; 8(2):e55625. PubMed ID: 23405181
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes mellitus and chronic hepatitis C: which is worse? Results of a long-term retrospective cohort study.
Giordanino C; Ceretto S; Bo S; Smedile A; Ciancio A; Bugianesi E; Pellicano R; Fagoonee S; Versino E; Costa G; Arese D; Sacco M; Rizzetto M; Saracco G
Dig Liver Dis; 2012 May; 44(5):406-12. PubMed ID: 22245505
[TBL] [Abstract][Full Text] [Related]
19. Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients.
Cardoso CR; Salles GF
J Diabetes Complications; 2008; 22(3):164-70. PubMed ID: 18413219
[TBL] [Abstract][Full Text] [Related]
20. Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients.
Zoppini G; Targher G; Chonchol M; Negri C; Stoico V; Pichiri I; Lippi G; Muggeo M; Bonora E
Atherosclerosis; 2010 Jun; 210(2):575-80. PubMed ID: 20031129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
